Pharmadrug Inc.

77 King Street West
Suite 2905
Toronto, ON
Canada M5K 1H1

Recent News

  • Pharmadrug Announces Positive Research Results of Cepharanthine to Treat Multiple Cancers

    Validates Cepharanthine's potential in treating various cancers with unsatisfactory treatment optionsPositions Cepharanthine's 'pipeline in a pill' strategy focusing on esophageal, colorectal, liver and skin cancersAdvance to FDA IND-enabling studies to support human clinical studiesToronto, Ontario--(Newsfile Corp. - July 28, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce...

    2021-07-28 8:51 AM EDT
  • PharmaDrug Announces Stock Ticker Symbol Change to (CSE: PHRX)

    Toronto, Ontario--(Newsfile Corp. - July 23, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that it will change its ticker symbol from "BUZZ" to "PHRX". The Company expects the symbol change to take effect on August 3, 2021. The change in the ticker symbol is being made...

    2021-07-23 8:00 AM EDT
  • PharmaDrug Reports Positive Preclinical Study Results of Cepharanthine to Treat Cancers

    Toronto, Ontario--(Newsfile Corp. - July 14, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce interim positive results from its ongoing preclinical study evaluating the Company's patented enteric-coated formulation of Cepharanthine ("PD-001") in a broad panel of human cancers. The study is conducted by a respected contract...

    2021-07-14 7:45 AM EDT
  • PharmaDrug Announces Change of Auditor

    Toronto, Ontario--(Newsfile Corp. - July 12, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, today announced that MNP LLP (the "Former Auditor") has resigned as the Company's auditors, with the resignation being effective as of June 14, 2021. The Company's management and audit committee are in discussions with several auditors and...

    2021-07-12 5:18 PM EDT
  • PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Infectious Diseases Including COVID-19

    Toronto, Ontario--(Newsfile Corp. - June 22, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that the Company has initiated preparation of a Pre-Investigational New Drug Application (pre-IND) for its patented enteric-coated formulation of cepharanthine (PD-001), an oral antiviral pill to treat mild-moderate COVID-19.Vaccination programs aimed at controlling...

    2021-06-22 7:47 AM EDT
  • Pharmadrug's Supersmart Launches Psilocybin Online Retail Platform in the Netherlands

    Toronto, Ontario--(Newsfile Corp. - June 7, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that its Super Smart division has launched a Slim Winkel branded online retail platform in The Netherlands and Europe. The European Slim Winkel online store will sell psilocybin truffles as well as...

    2021-06-07 8:48 AM EDT
  • PharmaDrug's Super Smart Launches Online Retail Platform in the United States

    Toronto, Ontario--(Newsfile Corp. - May 17, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that its Super Smart division has launched a Slim Winkel branded online retail platform in the U.S. that will focus on functional mushrooms. The introduction of a specialty online shop featuring a...

    2021-05-17 7:49 AM EDT
  • PharmaDrug Signs Supply Agreement with European Cannabis Extractor for Medical Grade THC Oil to Be Sold Under PharmaDrug Brand

    Toronto, Ontario--(Newsfile Corp. - May 14, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce that it has entered into a supply agreement (the "Supply Agreement") with an emerging Eurozone cannabis extractor for medical grade THC oil to be sold under PharmaDrug's own brand. The Company expects to...

    2021-05-14 9:25 AM EDT